https://www.gosh.nhs.uk/our-research/our-research-infrastructure/nihr-great-ormond-street-hospital-brc/brc-news/gosh-announced-lead-new-europe-wide-epilepsy-network/
GOSH announced as lead for new Europe-wide epilepsy network
30 Mar 2017, 11:31 a.m.
Great Ormond Street Hospital (GOSH) has been announced as the lead in a new Europe-wide epilepsy network, aiming to increase collaborations across Europe and improve access to innovative and highly-specialised diagnostics.
EpiCARE is a European Reference Network funded by the European Commission and led by BRC-funded Professor Helen Cross.
The network will enable collaborative working across Europe to develop and deliver highly-specialised diagnostics, such as advanced structural brain imaging and molecular and metabolic diagnostics, and aims to improve treatments and outcomes in patients with rare or complex epilepsy. The network will be made up of 28 care providers across Europe and will run from 2017 to 2021.
New 'Secure Data Environment' joint offering from GOSH and Aridhia to accelerate clinical research and healthcare innovation
We are expanding our partnership with Aridhia to include an offer to external partners.
Join us in the countdown to Rare Disease Day 2025
Rare Disease Day takes place annually on the last day of February and is a global opportunity to increase awareness and advocate for those living with rare conditions.
Could adapting our sinks help combat superbugs?
Discover how a Consultant Microbiologist at GOSH turned an innovative idea into a patented product that could revolutionise infection control in hospitals, schools, and airports – helping to stop superbugs like MRSA.
GOSH pilots AI tool to give clinicians more quality-time with patients
Patients and clinicians at GOSH have been taking part in the first NHS trial of a bespoke healthcare AI assistant, TORTUS, to help increase face-to-face time during appointments.